Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Accumulated Depreciation, Depletion, and Amortization
QFR218385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
126,862.00
Year-over-Year Change
9.79%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks accumulated depreciation, depletion, and amortization for U.S. pharmaceutical and medicines corporations, providing insight into capital investment and asset value reduction. It serves as a critical indicator of industry capital expenditure and long-term asset management strategies.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
Accumulated depreciation represents the total reduction in value of a corporation's tangible and intangible assets over time, reflecting ongoing capital investment and asset lifecycle management. Economists use this metric to assess industry capital intensity, investment patterns, and potential technological reinvestment.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations, aggregated and standardized by federal economic reporting agencies.
Historical Context
This trend helps policymakers and investors understand capital investment trends, technological reinvestment, and long-term financial health in the pharmaceutical sector.
Key Facts
- Tracks cumulative asset value reduction in pharmaceutical corporations
- Provides insights into long-term capital investment strategies
- Reflects technological reinvestment and asset lifecycle management
FAQs
Q: What does accumulated depreciation indicate?
A: Accumulated depreciation shows the total reduction in value of a corporation's assets over time, reflecting ongoing capital investment and asset wear.
Q: Why is this trend important for investors?
A: It helps investors understand a company's capital investment strategies, asset management, and potential for technological reinvestment.
Q: How is this data collected?
A: Data is gathered through quarterly financial reports submitted by pharmaceutical corporations and standardized by federal economic reporting agencies.
Q: What can this trend reveal about the pharmaceutical industry?
A: It provides insights into capital intensity, technological investment, and long-term financial health of pharmaceutical corporations.
Q: How frequently is this data updated?
A: The data is typically updated quarterly, providing a consistent view of corporate asset management over time.
Related Trends
Quarterly Financial Report: U.S. Corporations: All Other Professional and Technical Services, Except Legal Services: All Other Current Liabilities
QFRD315549USNO
Contributions to the Chicago Fed Midwest Economy Index: Consumer Spending Contribution
CONSUMERM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Beverage and Tobacco Products: Inventories
QFR214312USNO
Quarterly Financial Report: U.S. Corporations: All Wholesale Trade: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326WHSUSNO
Quarterly Financial Report: U.S. Corporations: All Durable Manufacturing: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326DURUSNO
Contributions to the Chicago Fed Relative Midwest Economy Index: Iowa Contribution: Services Sector
RSERVIAM683SFRBCHI
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Accumulated Depreciation, Depletion, and Amortization [QFR218385USNO], retrieved from FRED.
Last Checked: 8/1/2025